Herbs (Global Traditional) · European
Juniper Berry (Juniperus communis) (Juniperus communis)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Juniper berry (Juniperus communis) contains α-pinene, myrcene, and sabinene as primary bioactive compounds that exhibit anti-inflammatory and potential anti-cancer properties. These monoterpenes work by inhibiting inflammatory pathways and inducing apoptosis in cancer cells.
Juniper berry refers to the ripe, aromatic cones of the evergreen shrub Juniperus communis (family Cupressaceae), native to Europe, Asia, and North America, commonly harvested from wild populations in temperate regions such as north-east Slovakia and the Republic of Tatarstan. The berries are typically processed into extracts using 70% ethanol or methanol solvents, yielding polyphenolic and terpenoid-rich extracts, with essential oils obtained via steam distillation.
No human clinical trials, RCTs, or meta-analyses were identified in the available research. Evidence is limited to preclinical in vitro studies on HepG2 cancer cells and animal models including mouse xenograft studies (n=5/group) and rat colon cancer models (n=32), with no PMIDs provided in the research dossier.
Animal studies used: subcutaneous extract at 200 mg/kg every 2 days (mice), oral juniper oil at 100 µl/kg daily (rats), and methanolic extract at 12.5-25 mg/kg (mice). No human dosage data or standardization protocols are available. Consult a healthcare provider before starting any new supplement.
Juniper berries (Juniperus communis) contain a complex array of macronutrients, micronutrients, and bioactive compounds. Per 100g of dried berries: Carbohydrates ~50-55g (primarily sugars and complex polysaccharides), dietary fiber ~25-30g (notably insoluble fiber), fat ~7-10g (including fixed oils rich in fatty acids), protein ~4-6g. Key micronutrients include Vitamin C (~8-10mg/100g dried), Vitamin E (tocopherols, ~2-3mg/100g), Calcium (~100-115mg/100g), Potassium (~170-180mg/100g), Magnesium (~30-40mg/100g), Iron (~2-3mg/100g), Manganese (~1.5-2mg/100g), and Copper (~0.3mg/100g). The primary bioactive constituents are: (1) Essential oil (0.5-3.4% of dry weight), dominated by monoterpene hydrocarbons — alpha-pinene (30-60% of essential oil), beta-pinene (~5-12%), sabinene (~5-15%), myrcene (~2-8%), limonene (~2-5%), and sesquiterpenes including beta-caryophyllene (~3-6%); (2) Flavonoids including amentoflavone (~0.1-0.3% dry weight), quercetin, apigenin, and rutin; (3) Diterpenes such as communic acid and isocommunic acid; (4) Catechins and proanthocyanidins (condensed tannins, ~2-5% dry weight); (5) Lignans including desoxypodophyllotoxin; (6) Organic acids including ascorbic acid, malic acid, and shikimic acid; (7) Monoterpene alcohols: terpinen-4-ol (~4-8% of essential oil), a key diuretic compound. Bioavailability notes: Essential oil constituents are highly lipophilic and are best absorbed in the presence of dietary fats; terpinen-4-ol demonstrates good gastrointestinal absorption. Polyphenols and flavonoids have variable bioavailability (~5-20%) due to glycosylation and matrix effects, with colonic microbiota playing a significant role in their metabolism. Tannins may bind dietary proteins and reduce their absorption when consumed in large quantities. Amentoflavone is notably poorly bioavailable orally due to extensive first-pass metabolism.
Juniper berry's monoterpenes, particularly α-pinene and myrcene, inhibit nuclear factor-kappa B (NF-κB) signaling pathways, reducing inflammatory cytokine production. These compounds also induce apoptosis in cancer cells through activation of caspase-3 and downregulation of Bcl-2 anti-apoptotic proteins. The essential oil components modulate cyclooxygenase-2 (COX-2) enzyme activity, contributing to anti-inflammatory effects.
Animal studies demonstrate juniper extract's anti-cancer potential, with 200 mg/kg doses reducing HepG2 liver tumor volume in mice and improving survival rates. Rat studies using 100 µl/kg juniper oil showed reduced colon adenoma and adenocarcinoma incidence. However, human clinical trials are lacking, limiting the strength of evidence for therapeutic applications. Current research remains in preliminary preclinical stages with small sample sizes.
Juniper berry may cause kidney irritation and should be avoided by individuals with kidney disease or during pregnancy due to potential uterine stimulation. It can interact with diuretic medications, potentially enhancing their effects and leading to electrolyte imbalances. Large doses may cause gastrointestinal upset, diarrhea, and skin irritation. Long-term use is not recommended due to potential nephrotoxicity from volatile oils.
